News
-
-
COMMUNIQUÉ DE PRESSE
Pyrum and UNITANK establish joint venture for the construction and operation of up to ten End-of-Life Tyre Recycling Plants in Europe
Pyrum and UNITANK establish joint venture to build and operate End-of-Life Tyre Recycling Plants in Europe, with UniPyrum as the independent company in charge of the new state-of-the-art facilities -
COMMUNIQUÉ DE PRESSE
SFC Energy AG expands strategic partnership with Linc Polska – New framework agreement signed for 2026
SFC Energy AG expands strategic partnership with Linc Polska through new EUR 1.5 million framework agreement for 2026, focusing on fuel cells for mobile surveillance solutions in Central Europe -
-
COMMUNIQUÉ DE PRESSE
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
Valneva SE to meet with investors at the J.P. Morgan Healthcare Conference to discuss upcoming catalysts from its clinical development pipeline and commercial portfolio of vaccines. Company specializes in prophylactic vaccines for infectious diseases -
COMMUNIQUÉ DE PRESSE
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference
Valneva SE rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference à San Francisco pour discuter des avancées de son portefeuille de vaccins et des résultats attendus pour le vaccin contre la maladie de Lyme -
COMMUNIQUÉ DE PRESSE
GURIT ANNOUNCES MAJOR NEW LONG-TERM SUPPLY AGREEMENT WITH A LEADING WIND OEM
Gurit Holding AG announces a major new long-term supply agreement with a leading wind turbine OEM. The landmark contract will generate approximately CHF 250 million in net sales over the next five years -
-
COMMUNIQUÉ DE PRESSE
BEACN Welcomes New Director Charles Huang and Closes Final Tranche of Non-Brokered Private Placement
BEACN announces Charles Huang as new board member. Closes final tranche of private placement for $700,000. Company developing innovative audio equipment for gamers, live streamers, and content creators -
COMMUNIQUÉ DE PRESSE
LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP-1/GIP Platform
LIR Life Sciences Corp. enters R&D Agreement with Neuland Labs for peptide formulations. Neuland Labs to provide services for preclinical evaluation and future collaboration
